A Phase I Study of Intraperitoneal Hyperthermic Docetaxel

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Ovarian Carcinoma
Interventions
DRUG

docetaxel

Docetaxel will be administered in normal-saline delivered at an inflow temperature of 42 degreesC for 90 minutes by the technique described in Appendix D of the protocol

Trial Locations (1)

40202

James Graham Brown Cancer Center, Louisville

All Listed Sponsors
collaborator

James Graham Brown Cancer Center

OTHER

lead

University of Louisville

OTHER

NCT00474669 - A Phase I Study of Intraperitoneal Hyperthermic Docetaxel | Biotech Hunter | Biotech Hunter